Company Overview of Oxagen Limited
Oxagen Limited, a biopharmaceutical company, develops, manufactures, and commercializes anti-inflammatory medicines to treat asthma and other chronic allergic conditions. It develops and commercializes OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhinoconjunctivitis. The company’s drug programs targets the CRTH2 receptor that initiates and maintains allergic conditions. It also engages in developing a pipeline of small molecule drugs. The company serves customers in the United Kingdom, the Russian Federation, CIS countries, and internationally. Oxagen Limited was incorporated in 1996 and is based in Abingdon, United Kingdom.
99 Park Drive
Abingdon, OX14 4RY
Founded in 1996
44 12 3584 1561
44 1235 443301
Key Executives for Oxagen Limited
Similar Private Companies By Industry
|Dales Pharmaceuticals Limited||Europe|
|Takeda Global Research & Development Centre (Europe) Ltd.||Europe|
|KalVista Pharmaceuticals Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Oxagen Limited, please visit www.oxagen.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.